https://www.selleckchem.com/pr....oducts/incb059872-di
https://www.selleckchem.com/pr....oducts/incb059872-di
Real-world knowledge of treatments for backbone ganglioneuroma: long-term follow-up studies associated with Thirty one instances. The authors describe here their GMP- and European Pharmacopoeia-compliant production and quality control process, report on a pre-clinical dose selection study and present the first in-human results. Together, these data substantiate the idea that ABCB5 MSCs manufactured as ATMPs could deliver a clinically relevant w
Like
Comment
Share
